15 Minute News 15 Minute Fun
Follow Us
Sign In
Sign In
to Comment, Vote &
Create Storyboards.
Scientists report that GARP, a TGF-beta cell surface receptor, could be a novel diagnostic marker for breast, colon, and lung cancer. An antibody-based therapy targeting GARP prevented metastasis to the lung in a mouse model of breast cancer. Targeting GARP with an antibody could represent a novel addition to established immunotherapies that 'wake up' the immune system so that it can fight cancer.
0
views
0
likes
0
dislikes


Storyboard
Print


Share this Article



Similar Articles
Comments


Please Sign In to comment


##username##
##datetime##
##comment##
##commentlikeno##Likes
##commentdislikeno##Dislikes




Terms & Conditions | About | Enquiries | Advertise